Understanding Bioidentical Hormones: What Women Should Know About BHRT

Bioidentical vs. Synthetic: What the Terms Actually Mean

The word "bioidentical" refers to the molecular structure of the hormone, not how it's manufactured. Bioidentical hormones have the exact same chemical and molecular structure as the hormones your body produces naturally — estradiol, progesterone, and in some cases testosterone. This is in contrast to synthetic hormones like conjugated equine estrogen (derived from pregnant mare urine) and medroxyprogesterone acetate, which have different molecular structures than human hormones.

Here's where it gets important to be precise: bioidentical hormones are available in both FDA-approved and compounded forms.

FDA-approved bioidentical hormones

These include commercially manufactured products like micronized progesterone (Prometrium) and various estradiol formulations (patches, gels, sprays). They have undergone the FDA's review process for safety and efficacy. Several major medical organizations, including ACOG and the North American Menopause Society (NAMS), recommend FDA-approved hormone therapies as first-line treatment for menopausal symptoms.

Compounded bioidentical hormones

These are custom-prepared by compounding pharmacies according to a clinician's prescription. They can be formulated in specific doses and delivery methods (creams, troches, capsules) that may not be commercially available. However, compounded preparations have not undergone FDA review for safety, efficacy, or dosing consistency. The American College of Obstetricians and Gynecologists (ACOG) has noted that evidence to support claims that compounded bioidentical hormones are safer or more effective than FDA-approved formulations is currently lacking.

This distinction matters. When someone says they're on "bioidentical hormones," they could be taking an FDA-approved product or a compounded one — and the regulatory oversight, quality control, and evidence base differ between them.

What Does the Research Actually Show?

This is an area where honest communication matters more than marketing. Here's what the current evidence supports:

Hormone therapy is effective for menopausal symptoms

This is well-established. Both FDA-approved and bioidentical hormone preparations have demonstrated effectiveness in reducing hot flashes, night sweats, sleep disruption, vaginal dryness, and other menopausal symptoms. The 2022 NAMS position statement confirms hormone therapy as the most effective treatment for vasomotor symptoms (hot flashes and night sweats) and the genitourinary syndrome of menopause.

The timing of initiation matters

Research consistently shows that the benefit-to-risk ratio of hormone therapy is most favorable when started within 10 years of menopause onset or before age 60. This is sometimes called the "window of opportunity." For women in this window, the cardiovascular and overall health benefits may outweigh the risks. For women who are more than 10 years past menopause or over 60, the risk profile shifts. Most major medical societies — including the North American Menopause Society (NAMS) and the American College of Obstetricians and Gynecologists (ACOG) — support individualized hormone therapy when the benefits outweigh the risks for a given patient.

Claims that compounded BHRT is safer than FDA-approved HRT are not supported by current evidence

This is the uncomfortable truth that many BHRT marketing materials gloss over. While bioidentical hormones (including FDA-approved formulations) may differ in side effect profiles compared to synthetic non-bioidentical hormones depending on formulation and patient factors, the specific claim that compounded preparations are safer has not been demonstrated in large-scale clinical trials. ACOG's 2023 clinical consensus explicitly states that compounded bioidentical menopausal hormone therapy should not be routinely prescribed when FDA-approved alternatives exist.

That said, compounded formulations have a legitimate clinical role

ACOG also acknowledges that compounded preparations may be appropriate for some patients — for example, those who need a specific dose or delivery method not commercially available, or who have documented allergies to ingredients in FDA-approved products. The key is that the decision should be made with full informed consent about what compounded means, not based on marketing claims of superiority.

Risks and Considerations You Should Understand

Hormone therapy — whether bioidentical or synthetic, FDA-approved or compounded — carries risks that should be weighed against benefits on an individual basis. Your clinician will discuss these with you before prescribing.

Established risks of hormone therapy

Research, including data from the Women's Health Initiative and subsequent analyses, has identified the following potential risks associated with hormone therapy: increased risk of blood clots (venous thromboembolism), particularly with oral estrogen preparations; elevated stroke risk, especially with oral formulations; increased breast cancer risk with long-term combined estrogen-progesterone therapy; endometrial cancer risk with estrogen-only therapy in women with an intact uterus (progesterone is prescribed alongside estrogen specifically to mitigate this risk); and increased gallbladder disease risk.

These risks vary based on the type of hormones used, the route of administration (transdermal preparations generally carry lower clot risk than oral), the timing of initiation relative to menopause, and individual health factors.

Who should not use hormone therapy

Specific considerations for compounded preparations

Because compounded hormones are not subject to the same FDA manufacturing standards as commercially produced drugs, there may be variability between batches in terms of potency and purity. This is a recognized concern among regulatory bodies and medical organizations. At Optimized Health, we work with licensed compounding pharmacies that follow rigorous preparation standards — but it's important that you understand this distinction as part of your informed consent.